Nitric oxide mediates mecamylamine- and naloxone-precipitated nicotine withdrawal

European Journal of Pharmacology

Volumn 345, Issue 2, 1998, Pages

  Adams, Michael L ^a   Cicero, Theodore J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Nicotine dependence; Nitric oxide (NO)

Indexed keywords

MECAMYLAMINE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOKING CESSATION; WEIGHT REDUCTION;

ANIMALS; MALE; MECAMYLAMINE; NALOXONE; NG-NITROARGININE METHYL ESTER; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032546327     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00089-2     Document Type: Article

References (8)

1. G-nitro-L-arginine methyl ester. Life Sci. 52:1993;PL245.
2. Benowitz N.L. Pharmacology of nicotine: addiction and therapeutics. Annu. Rev. Pharmacol. Toxicol. 36:1996;597.
3. Malin D.H., Lake J.R., Newlin-Maultsby P., Roberts L.K., Lanier J.G., Carter V.A., Cunningham J.S., Wilson O.B. Rodent model of nicotine abstinence syndrome. Pharmacol. Biochem. Behav. 43:1992;779.
4. Malin D.H., Lake J.R., Carter V.A., Cunningham J.S., Wilson O.B. Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology. 112:1993;339.
5. Malin D.H., Lake J.R., Carter V.A., Cunningham J.S., Hebert K.M., Conradand D.L., Wilson O.B. The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat. Psychopharmacology. 115:1994;180.
6. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109.
7. Morley J.E., Flood J.F. Evidence that nitric oxide modulates food intake in mice. Life Sci. 49:1991;707.
8. Vaupel D.B., Kimes A.S., London E.D. Nitric oxide synthase inhibitors: preclinical studies of potential use for treatment of opioid withdrawal. Neuropsychopharmacology. 13:1995;315.